Framingham-based tools to calculate the global risk of coronary heart disease: a systematic review of tools for clinicians.
about
A critical dialogue: communicating with type 2 diabetes patients about cardiovascular riskCalibration of Proportional Hazards and Accelerated Failure Time ModelsAssessment and relevance of carotid intima-media thickness (C-IMT) in primary and secondary cardiovascular preventionDevelopment of life-expectancy tables for people with type 2 diabetesCommunity cardiovascular disease risk from cross-sectional general practice clinical data: a spatial analysis.Challenges in reproducing results from publicly available data: an example of sexual orientation and cardiovascular disease risk.Does the routine use of global coronary heart disease risk scores translate into clinical benefits or harms? A systematic review of the literature.Realising the potential of the family history in risk assessment and primary prevention of coronary heart disease in primary care: ADDFAM study protocol.A new method for determining physician decision thresholds using empiric, uncertain recommendations.Effects of nutrition and exercise health behaviors on predicted risk of cardiovascular disease among workers with different body mass index levels.Aspirin for primary cardiovascular prevention: when is it worth the risks?Traditional statistical methods for evaluating prediction models are uninformative as to clinical value: towards a decision analytic framework.Projections of preventable risks for cardiovascular disease in Canada to 2021: a microsimulation modelling approach.Predictors of late cardiovascular complications in survivors of hematopoietic cell transplantation.Use of global coronary heart disease risk assessment in practice: a cross-sectional survey of a sample of U.S. physicians.Coronary risk assessment by point-based vs. equation-based Framingham models: significant implications for clinical care.The continuing evolution of women's health.Evaluating an implementation strategy in cardiovascular prevention to improve prescribing of statins in Germany: an intention to treat analysis.Risk factors for ANA positivity in healthy personsCardiovascular disease in diabetes: where does glucose fit in?From hypertension control to global cardiovascular risk management: an educational intervention in a cluster-randomised controlled trial.The Fremantle Primary Prevention Study: a multicentre randomised trial of absolute cardiovascular risk reduction.Primary prevention of cardiovascular disease: a web-based risk score for seven British black and minority ethnic groupsAccuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review.Exercise Effects on Risk of Cardiovascular Disease among Iranian WomenFamily history assessment for colorectal cancer (CRC) risk analysis - comparison of diagram- and questionnaire-based web interfacesA CTSA agenda to advance methods for comparative effectiveness research.A patient-driven adaptive prediction technique to improve personalized risk estimation for clinical decision supportCardiovascular Disease Risk Factors in Ghana during the Rural-to-Urban Transition: A Cross-Sectional Study.Development and feasibility of a personalized, interactive risk calculator for knee osteoarthritis.Risk calculators predict failures of knee and hip arthroplasties: findings from a large health maintenance organization.A validated risk calculator to assess risk and rate of visual field progression in treated glaucoma patients.Personalized medicine for osteoarthritis: where are we now?Systematic review of implementation strategies for risk tables in the prevention of cardiovascular diseases.Prevalence of 10-year risk of cardiovascular diseases and associated risks in canadian adults: the contribution of cardiometabolic risk assessment introductionIs Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor? New Insights From the Framingham Offspring Study.Prediction of morbidity and mortality in patients with type 2 diabetesAssessing appropriateness of lipid management among patients with diabetes mellitus: moving from target to treatment.Association of cardiovascular risk using non-linear heart rate variability measures with the framingham risk score in a rural population.Electronic communications and home blood pressure monitoring (e-BP) study: design, delivery, and evaluation framework
P2860
Q28219258-6621F962-66E4-4CD4-93DB-4733258C711EQ29026803-293E2B9A-04D0-4D43-933C-E6089281EF3AQ30358810-9ACB69D2-C7D3-4D29-8D64-92C3F7F2AF78Q30486759-133B1B58-8D2D-4B29-AA11-4958386C1C18Q30900391-1B0C686D-9FBD-40CD-A8CE-B4519330399BQ31045128-FDAF38ED-5469-40F2-89B7-9DE6D9862F4CQ33325717-6DCE29CD-45AE-458A-AB1D-760C5FE300ECQ33509900-3442F908-3079-44E5-9B26-900936754DA9Q33551018-34A52E4A-8E99-47AC-BCB9-A1E8D6A38792Q33742454-0A1FC5CB-5DEA-473D-9236-ADB44617D1B1Q33774734-11B1F6DA-89C5-4EAA-9DEF-CC86ADDB5FD1Q33800997-C02ADB66-A455-4AB1-BBD3-FCC1D42CAD5DQ33872446-260FB04D-E82F-40BF-9658-A8564499CB60Q33926274-6262408A-154D-4E3D-B4F8-CA154C035E99Q34138140-30823A26-4F73-4BB6-B7B8-BDA8F765DA06Q34164321-F2A93FDD-6015-46DF-A03F-296C07BADCBBQ34733230-ACF94B2E-44C4-4901-8648-2C7FB729A1D3Q34790218-C244B7D7-2004-41EF-8CED-33CA4F173704Q35092882-045F4222-DC6C-45E0-99DC-EDD205FD4B03Q35137148-43DE6E81-8D67-4293-BF70-87EFD2C89A3CQ35590918-429F123D-A22C-49D7-91C9-811E298EF03AQ35656371-B7E86400-C857-4BEA-8BDB-E849BC1442ADQ35772655-0565F12A-F1CD-4292-9595-18DBE0D51474Q35772791-374B38AF-68F1-4CCD-B109-FE7123B28C5DQ35786601-40D6EA92-CD57-436F-BCBA-A3E258E914F0Q35845805-166AA27F-E34F-4E41-80FE-833105A66CB2Q36054222-0F360E58-5E07-4E16-886B-825E5F8E83DAQ36085068-FAEA0087-2D71-4B94-8A4C-7FB7D78374F4Q36161379-9381A82D-1AA7-4121-82E8-DCA9198CB4B7Q36201923-1871268B-B30C-4919-AF71-322FFA2E8B09Q36226304-70823554-D834-4929-9F5E-900BB5744650Q36390585-133601B9-81AE-4762-8EC9-E40EBE2F30BBQ36800983-36877DCB-8416-45D2-B417-55B968B4F809Q36835827-9B08E5F7-A0E7-46BD-8762-2BB844AC866FQ36853724-7A4BBD59-C57A-481C-87F5-B1F9DED348D7Q36913493-92A9EDC9-C2B2-4723-B04B-62EE67DE3477Q36936666-10156B15-7EF8-459F-90C1-37C45A541867Q36975446-AC4B3323-6750-4270-98AF-0CDFE045FB0CQ37046605-51400E69-3447-4772-8DF5-4C8A91CB4386Q37103760-17DDE9FF-B129-4947-8ABE-B10F30653B37
P2860
Framingham-based tools to calculate the global risk of coronary heart disease: a systematic review of tools for clinicians.
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Framingham-based tools to calc ...... eview of tools for clinicians.
@ast
Framingham-based tools to calc ...... eview of tools for clinicians.
@en
Framingham-based tools to calc ...... eview of tools for clinicians.
@nl
type
label
Framingham-based tools to calc ...... eview of tools for clinicians.
@ast
Framingham-based tools to calc ...... eview of tools for clinicians.
@en
Framingham-based tools to calc ...... eview of tools for clinicians.
@nl
prefLabel
Framingham-based tools to calc ...... eview of tools for clinicians.
@ast
Framingham-based tools to calc ...... eview of tools for clinicians.
@en
Framingham-based tools to calc ...... eview of tools for clinicians.
@nl
P2860
P1476
Framingham-based tools to calc ...... eview of tools for clinicians.
@en
P2093
Cynthia Mulrow
Stacey Sheridan
P2860
P304
P356
10.1111/J.1525-1497.2003.30107.X
P577
2003-12-01T00:00:00Z
P5875
P6179
1007715351